A new study shows that complications from the abortion pill are 22 times higher than the 0.5 % claimed by the FDA. The FDA says that complications from Mifeprex are less than 0.5% but this study refutes that.
Authors from the Ethics & Public Policy Center (EPPC) analyzed 865,727 prescriptions of mifepristone distributed to 692,873 women between 2017 and 2023. They found that 10.9 percent of those women experienced potentially life-threatening “serious adverse events” within 45 days, including emergency room visits, hemorrhage, sepsis, infection, and follow-up surgeries.
The media regularly hides the truth about abortion from women. To their mind, it is as easy as taking a Tylenol for a headache. They hide data showing that abortion is associated with an increased risk of breast cancer. They probably won’t report on this study either.
EPPC President Ryan Anderson had this to say about it: “This study is the statistical equivalent of a category 5 hurricane hitting the prevailing narrative of the abortion industry. It reveals, based on real-world data, the shocking number of women who suffer serious medical consequences because of the abortion pill. The Trump FDA should take immediate action to protect the safety of American women by reinstating the safety regulations that the Obama and Biden Administrations removed.”